Serratia marcescens JCM 20091 is a bacterium of the family Yersiniaceae.
16S sequence Bacteria
SI-ID 219037
| @ref 20215 |
Last LPSN update
2026-02-09 11:39:28 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Yersiniaceae |
| Genus Serratia |
| Species Serratia marcescens |
| Full scientific name Serratia marcescens Bizio 1823 (Approved Lists 1980) |
| Synonyms (1) |
Global distribution of 16S sequence LC571942 (>99% sequence identity) for Serratia marcescens from Microbeatlas 
 Aquatic Samples |
2336 |
 Soil Samples |
1270 |
 Animal Samples |
18103 |
 Plant Samples |
995 |
| Total Samples | 22704 |
| @ref | Description | Accession | Length | Database | NCBI tax ID | |
|---|---|---|---|---|---|---|
| 67770 | Serratia marcescens JCM 20091 gene for 16S rRNA, partial sequence | LC571942 | 1464 |  | 615 |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative. | Asahara M, Tsuji A, Goto S, Masuda K, Kiuchi A. | Antimicrob Agents Chemother | 10.1128/aac.33.8.1144 | 1989 |  |
| Pathogenicity | In vitro and in vivo activity of DL-8280, a new oxazine derivative. | Sato K, Matsuura Y, Inoue M, Une T, Osada Y, Ogawa H, Mitsuhashi S. | Antimicrob Agents Chemother | 10.1128/aac.22.4.548 | 1982 | |
| Metabolism | In vitro antibacterial activity of Sch 34343 and its stability to beta-lactamases and renal dehydropeptidase 1. | Matsuda K, Sasaki K, Inoue K, Kondo H, Inoue M, Mitsuhashi S. | Antimicrob Agents Chemother | 10.1128/aac.28.5.684 | 1985 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive162744.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License